Stem cells and the endocrine pancreas

British Medical Bulletin

Volumn 100, Issue 1, 2011, Pages 123-135

  Wu, Yue ^a   Persaud, Shanta J ^a   Jones, Peter M ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

adult stem cells; cell therapy; diabetes; embryonic stem cells; insulin; pancreatic cell

Indexed keywords

ARTICLE; B LYMPHOCYTE; CELL DIFFERENTIATION; CELL FUNCTION; CELL MATURATION; CELL POPULATION; CELL PROLIFERATION; DIABETES MELLITUS; EMBRYONIC STEM CELL; HUMAN; IN VITRO STUDY; IN VIVO STUDY; PANCREAS ISLET; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION;

DIABETES MELLITUS, TYPE 1; EMBRYONIC STEM CELLS; HUMANS; INSULIN-SECRETING CELLS; ISLETS OF LANGERHANS; PLURIPOTENT STEM CELLS; STEM CELL TRANSPLANTATION;

EID: 83255177061     PISSN: 00071420     EISSN: 14718391     Source Type: Journal    
DOI: 10.1093/bmb/ldr021     Document Type: Article

References (49)

1. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010;87:4-14.
2. Huang ES, Basu A, O'Grady M et al. Projecting the future diabetes population size and related costs for the U.S. Diabetes Care 2009;32:2225-9.
3. de Kort H, de Koning EJ, Rabelink TJ et al. Islet transplantation in type 1 diabetes. BMJ 2011;342:d217.
4. Fiorina P, Shapiro AM, Ricordi C et al. The clinical impact of islet transplantation. Am J Transplant 2008;8:1990-7.
5. Halban PA, Kahn SE, Lernmark A et al. Gene and cell-replacement therapy in the treatment of type 1 diabetes: how high must the standards be set. Diabetes 2001;50:2181-91. (Pubitemid 33641899)
6. Jones PM, Persaud SJ. Islet function and insulin secretion. In: Holt RIG, Cockram CS, Flyvbjerg A et al. (eds). Textbook of Diabetes, 4th edn. Oxford: Wiley-Blackwell, 2010,87-103.
7. Parnaud G, Bosco D, Berney T et al. Proliferation of sorted human and rat beta cells. Diabetologia 2008;51:91-100. (Pubitemid 50002201)
8. Shaw JA, Delday MI, Hart AW et al. Secretion of bioactive human insulin following plasmidmediated gene transfer to non-neuroendocrine cell lines, primary cultures and rat skeletal muscle in vivo. J Endocrinol 2002;172:653-72. (Pubitemid 34232707)
9. Newgard CB, Clark S, BeltrandelRio H et al. Engineered cell lines for insulin replacement in diabetes: current status and future prospects. Diabetologia 1997;40(Suppl. 2):S42-7. (Pubitemid 27306921)
10. Efrat S. Beta-cell replacement for insulin-dependent diabetes mellitus. Adv Drug Deliv Rev 2008;60:114-23. (Pubitemid 350236395)
11. Wagner RT, Lewis J, Cooney A et al. Stem cell approaches for the treatment of type 1 diabetes mellitus. Transl Res 2010;156:169-79.
12. Dor Y, Brown J, Martinez OI et al. Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation. Nature 2004;429:41-6. (Pubitemid 38620543)
13. Thorel F, Nepote V, Avril I et al. Conversion of adult pancreatic alpha-cells to beta-cells after extreme beta-cell loss. Nature 2010;464:1149-54.
14. Zhao M, Amiel SA, Christie MR et al. Evidence for the presence of stem cell-like progenitor cells in human adult pancreas. J Endocrinol 2007;195:407-14.
15. Bonner-Weir S, Taneja M, Weir GC et al. In vitro cultivation of human islets from expanded ductal tissue. Proc Natl Acad Sci USA 2000;97:7999-8004. (Pubitemid 30460762)
16. Zulewski H, Abraham EJ, Gerlach MJ et al. Multipotential nestin-positive stem cells isolated from adult pancreatic islets differentiate ex vivo into pancreatic endocrine, exocrine, and hepatic phenotypes. Diabetes 2001;50:521-33. (Pubitemid 32195216)
17. Ianus A, Holz GG, Theise ND et al. In vivo derivation of glucose-competent pancreatic endocrine cells from bone marrow without evidence of cell fusion. J Clin Invest 2003;111:843-50. (Pubitemid 37074959)
18. Tang DQ, Cao LZ, Burkhardt BR et al. In vivo and in vitro characterization of insulinproducing cells obtained from murine bone marrow. Diabetes 2004;53:1721-32. (Pubitemid 38857030)
19. Karnieli O, Izhar-Prato Y, Bulvik S et al. Generation of insulin-producing cells from human bone marrow mesenchymal stem cells by genetic manipulation. Stem Cells 2007;25:2837-44. (Pubitemid 350127868)
20. Hasegawa Y, Ogihara T, Yamada T et al. Bone marrow (BM) transplantation promotes betacell regeneration after acute injury through BM cell mobilization. Endocrinology 2007;148:2006-15. (Pubitemid 46997048)
21. Ferber S, Halkin A, Cohen H et al. Pancreatic and duodenal homeobox gene 1 induces expression of insulin genes in liver and ameliorates streptozotocin-induced hyperglycemia. Nat Med 2000;6:568-72. (Pubitemid 30305908)
22. Perl S, Hirshberg B, Harlan DM et al. How much insulin is enough? A quantitative assessment of the transdifferentiaton potential of liver. Diabetologia 2007;50:690-2. (Pubitemid 46215514)
23. Yechoor V, Liu V, Espiritu C et al. Neurogenin3 is sufficient for transdetermination of hepatic progenitor cells into neo-islets in vivo but not transdifferentiation of hepatocytes. Dev Cell 2009;16:358-73.
24. Zhou Q, Brown J, Kanarek A et al. In vivo reprogramming of adult pancreatic exocrine cells to beta-cells. Nature 2008;455:627-32.
25. Soria B, Roche E, Berna G et al. Insulin-secreting cells derived from embryonic stem cells normalize glycemia in streptozotocin-induced diabetic mice. Diabetes 2000;49:157-62. (Pubitemid 30070992)
26. Assady S, Maor G, Amit M et al. Insulin production by human embryonic stem cells. Diabetes 2001;50:1691-7. (Pubitemid 33641584)
27. Lumelsky N, Blondel O, Laeng P et al. Differentiation of embryonic stem cells to insulinsecreting structures similar to pancreatic islets. Science 2001;292:1389-94. (Pubitemid 32476228)
28. Hansson M, Madsen OD. Pluripotent stem cells, a potential source of beta-cells for diabetes therapy. Curr Opin Investig Drugs 2010;11:417-25.
29. Jones PM, Burns CJ, Persaud SJ. Beta cell replacement technologies: the potential of stem cells for transplantation therapy for Type 1 diabetes. Drug Discov Today 2004;1:213-7.
30. Jorgensen MC, Ahnfelt-Ronne J, Hald J et al. An illustrated review of early pancreas development in the mouse. Endocr Rev 2007;28:685-705. (Pubitemid 47606652)
31. D'Amour KA, Agulnick AD, Eliazer S et al. Efficient differentiation of human embryonic stem cells to definitive endoderm. Nat Biotechnol 2005;23:1534-41. (Pubitemid 41752931)
32. Xu X, Kahan B, Forgianni A et al. Endoderm and pancreatic islet lineage differentiation from human embryonic stem cells. Cloning Stem Cells 2006;8:96-107. (Pubitemid 43993243)
33. Jiang W, Shi Y, Zhao D et al. In vitro derivation of functional insulin-producing cells from human embryonic stem cells. Cell Res 2007;17:333-44. (Pubitemid 46639938)
34. D'Amour KA, Bang AG, Eliazer S et al. Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells. Nat Biotechnol 2006;24:1392-401. (Pubitemid 44722103)
35. Kroon E, Martinson LA, Kadoya K et al. Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo. Nat Biotechnol 2008;26:443-52. (Pubitemid 351501814)
36. Zhang D, Jiang W, Liu M et al. Highly efficient differentiation of human ES cells and iPS cells into mature pancreatic insulin-producing cells. Cell Res 2009;19:429-38.
37. Cho YM, Lim JM, Yoo DH et al. Betacellulin and nicotinamide sustain PDX1 expression and induce pancreatic beta-cell differentiation in human embryonic stem cells. Biochem Biophys Res Commun 2008;366:129-34. (Pubitemid 350297223)
38. Courtney ML, Jones PM, Burns CJ. Importance of quantitative analysis in the generation of insulin-expressing cells from human embryonic stem cells. Pancreas 2010;39:105-7.
39. Shim JH, Kim SE, Woo DH et al. Directed differentiation of human embryonic stem cells towards a pancreatic cell fate. Diabetologia 2007;50:1228-38. (Pubitemid 46701546)
40. Jiang J, Au M, Lu K et al. Generation of insulin-producing islet-like clusters from human embryonic stem cells. Stem Cells 2007;25:1940-53. (Pubitemid 47258172)
41. Talavera-Adame D, Wu G, He Y et al. Endothelial cells in co-culture enhance embryonic stem cell differentiation to pancreatic progenitors and insulin-producing cells through BMP signaling. Stem Cell Rev 2011. Epub before print.
42. Jeon J, Correa-Medina M, Ricordi C et al. Endocrine cell clustering during human pancreas development. J Histochem Cytochem 2009;57:811-24.
43. Matveyenko AV, Georgia S, Bhushan A et al. Inconsistent formation and nonfunction of insulin-positive cells from pancreatic endoderm derived from human embryonic stem cells in athymic nude rats. Am J Physiol Endocrinol Metab 2010;299:E713-20.
44. Tateishi K, He J, Taranova O et al. Generation of insulin-secreting islet-like clusters from human skin fibroblasts. J Biol Chem 2008;283:31601-7.
45. Maehr R, Chen S, Snitow M et al. Generation of pluripotent stem cells from patients with type 1 diabetes. Proc Natl Acad Sci USA 2009;106:15768-73.
46. Hanna JH, Saha K, Jaenisch R. Pluripotency and cellular reprogramming: facts, hypotheses, unresolved issues. Cell 2010;143:508-25.
47. Lister R, Pelizzola M, Kida YS et al. Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Nature 2011. Epub before print.
48. Hussein SM, Batada NN, Vuoristo S et al. Copy number variation and selection during reprogramming to pluripotency. Nature 2011;471:58-62.
49. Gore A, Li Z, Fung HL et al. Somatic coding mutations in human induced pluripotent stem cells. Nature 2011;471:63-7.